Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HUM logo HUM
Upturn stock rating
HUM logo

Humana Inc (HUM)

Upturn stock rating
$262.17
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/15/2025: HUM (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

26 Analysts rated it

Well-followed company, solid analyst reports, reliable data for confident investing.

1 Year Target Price $294.54

1 Year Target Price $294.54

Analysts Price Target For last 52 week
$294.54 Target price
52w Low $206.15
Current$262.17
52w High $314.25

Analysis of Past Performance

Type Stock
Historic Profit -38.97%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/15/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 33.08B USD
Price to earnings Ratio 21.06
1Y Target Price 294.54
Price to earnings Ratio 21.06
1Y Target Price 294.54
Volume (30-day avg) 26
Beta 0.42
52 Weeks Range 206.15 - 314.25
Updated Date 10/17/2025
52 Weeks Range 206.15 - 314.25
Updated Date 10/17/2025
Dividends yield (FY) 1.32%
Basic EPS (TTM) 13.06

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 1.28%
Operating Margin (TTM) 3.58%

Management Effectiveness

Return on Assets (TTM) 4.69%
Return on Equity (TTM) 9.03%

Valuation

Trailing PE 21.06
Forward PE 18.52
Enterprise Value 39410154191
Price to Sales(TTM) 0.27
Enterprise Value 39410154191
Price to Sales(TTM) 0.27
Enterprise Value to Revenue 0.32
Enterprise Value to EBITDA -
Shares Outstanding 120271819
Shares Floating 120044505
Shares Outstanding 120271819
Shares Floating 120044505
Percent Insiders 0.21
Percent Institutions 96.13

ai summary icon Upturn AI SWOT

Humana Inc

stock logo

Company Overview

overview logo History and Background

Humana Inc. was founded in 1961 as a nursing home company called Extendicare. It later transitioned into hospital management and then into health insurance in the 1980s, focusing on managed care. It has since grown to be a major player in the health insurance industry, particularly in the Medicare Advantage market.

business area logo Core Business Areas

  • Retail: This segment primarily focuses on individual consumers, offering Medicare Advantage plans, prescription drug plans, and other healthcare-related products and services.
  • Group and Specialty: This segment provides employer-sponsored health plans, including medical, dental, and vision coverage, as well as specialty benefits such as life insurance and stop-loss insurance.
  • Healthcare Services: This segment focuses on providing integrated care delivery services through primary care practices, pharmacies, and other healthcare facilities.

leadership logo Leadership and Structure

Humana is led by Bruce D. Broussard (President & CEO). The organizational structure consists of various divisions and departments, including operations, finance, marketing, and technology, with a centralized management team overseeing the overall strategy and performance of the company.

Top Products and Market Share

overview logo Key Offerings

  • Medicare Advantage Plans: Humana's Medicare Advantage plans are a major product, offering comprehensive health coverage to seniors. They are a leading provider of Medicare Advantage plans. Competitors include UnitedHealth Group (UNH), CVS Health (CVS), and Cigna (CI).
  • Prescription Drug Plans (PDP): Humana offers standalone prescription drug plans for individuals enrolled in Original Medicare. Market share data is competitive. Competitors are the same as above: UNH, CVS, CI, and Elevance Health (ELV).
  • Employer-Sponsored Health Plans: Humana provides health insurance and benefits administration services to employers of all sizes. Market share data is competitive. Competitors include UNH, ELV, Aetna (CVS), and Cigna (CI).

Market Dynamics

industry overview logo Industry Overview

The health insurance industry is characterized by increasing competition, rising healthcare costs, regulatory changes, and a growing focus on value-based care. The industry is consolidated with the top few players controlling a large segment of the market share.

Positioning

Humana is a major player in the health insurance market, particularly in Medicare Advantage. Its competitive advantages include a large membership base, strong brand recognition, and investments in technology and integrated care delivery.

Total Addressable Market (TAM)

The TAM for health insurance in the US is estimated to be over $1 trillion. Humana is well-positioned to capture a significant share of this market, particularly in the Medicare Advantage segment.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition
  • Large membership base
  • Extensive provider network
  • Focus on Medicare Advantage
  • Investment in technology and innovation

Weaknesses

  • Exposure to regulatory changes
  • Dependence on government funding
  • High administrative costs
  • Potential for adverse selection
  • Concentration in certain geographic markets

Opportunities

  • Expanding Medicare Advantage market
  • Growing demand for value-based care
  • Increasing adoption of telehealth
  • Acquisitions and partnerships
  • New product development

Threats

  • Increased competition
  • Rising healthcare costs
  • Regulatory changes
  • Cybersecurity risks
  • Economic downturn

Competitors and Market Share

competitor logo Key Competitors

  • UNH
  • CVS
  • ELV
  • CI

Competitive Landscape

Humana faces strong competition from other major health insurers. Its advantages include a strong brand and focus on Medicare Advantage, while its disadvantages may include higher administrative costs compared to some competitors.

Major Acquisitions

Kindred at Home

  • Year: 2021
  • Acquisition Price (USD millions): 5700
  • Strategic Rationale: Expansion of home health services to improve patient outcomes and reduce costs.

Growth Trajectory and Initiatives

Historical Growth: Humana has experienced growth in revenue and membership over the past years, driven by the expansion of its Medicare Advantage business and acquisitions.

Future Projections: Future growth projections depend on analyst estimates and market conditions. These projections are not available in the provided context.

Recent Initiatives: Recent initiatives likely include investments in technology, expansion of telehealth services, and acquisitions to expand its footprint in different markets.

Summary

Humana is a major player in the health insurance industry, particularly in the Medicare Advantage market, with a strong brand and extensive network. It faces challenges from increased competition, rising healthcare costs, and regulatory changes. The company is strategically focusing on growth through acquisitions, technology investments, and value-based care models. Humana will need to manage costs and adapt to evolving market dynamics to maintain its competitive position.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings
  • Industry Reports
  • Analyst Estimates

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Humana Inc

Exchange NYSE
Headquaters Louisville, KY, United States
IPO Launch date 1993-01-22
President, CEO & Director Mr. James A. Rechtin M.B.A.
Sector Healthcare
Industry Healthcare Plans
Full time employees 65680
Full time employees 65680

Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.